Last reviewed · How we verify
LNTH-2403
At a glance
| Generic name | LNTH-2403 |
|---|---|
| Sponsor | Radiopharm Theranostics, Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors. (PHASE1)
- Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |